Pharma stocks surged today after a tariff-related report boosted investor sentiment. The U.S. administration is reportedly considering reducing tariffs on drugs and medical products from countries like India. This move could significantly benefit Indian pharma giants such as Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Aurobindo. Experts believe this policy